Colgate-Palmolive delivered a 2% increase in net sales and maintained flat adjusted EPS, as lower private label pet sales and margin contraction weighed on performance. Organic growth was limited but the company reaffirmed its full-year guidance.
Net sales rose 2% to $5.13 billion, driven by strong pricing offset by volume declines.
Organic sales growth was 0.4%, reflecting pressure from exiting private label pet business.
Net income was $735 million with diluted EPS of $0.91.
Operating profit margin decreased 60 basis points to 20.6%.
Colgate reaffirmed its EPS guidance and updated its full-year 2025 organic sales growth target to 1–2% from 2–4% previously.
Visualization of income flow from segment revenue to net income